SARS-CoV2 variant-specific replicating RNA vaccines protect from disease following challenge with heterologous variants of concern

Despite mass public health efforts, the SARS-CoV2 pandemic continues as of late 2021 with resurgent case numbers in many parts of the world. The emergence of SARS-CoV2 variants of concern (VoCs) and evidence that existing vaccines that were designed to protect from the original strains of SARS-CoV-2...

Descripción completa

Detalles Bibliográficos
Autores principales: Hawman, David W, Meade-White, Kimberly, Archer, Jacob, Leventhal, Shanna S, Wilson, Drew, Shaia, Carl, Randall, Samantha, Khandhar, Amit P, Krieger, Kyle, Hsiang, Tien-Ying, Gale, Michael, Berglund, Peter, Fuller, Deborah Heydenburg, Feldmann, Heinz, Erasmus, Jesse H
Formato: Online Artículo Texto
Lenguaje:English
Publicado: eLife Sciences Publications, Ltd 2022
Materias:
Immunology and Inflammation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8983041/
https://www.ncbi.nlm.nih.gov/pubmed/35191378
http://dx.doi.org/10.7554/eLife.75537

Ejemplares similares

Ejemplares similares